Gene therapy for neurodegenerative disorders in children: dreams and realities
- 1 December 2023
- journal article
- research article
- Published by Elsevier in Archives de Pédiatrie
- Vol. 30 (8) , 8S32-8S40
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
- Novartis
This publication has 50 references indexed in Scilit:
- Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control PatientsJAMA Neurology, 2016
- Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trialThe Lancet, 2016
- Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman PrimatesHuman Gene Therapy Clinical Development, 2015
- Metachromatic leukodystrophy: Disease spectrum and approaches for treatmentBest Practice & Research Clinical Endocrinology & Metabolism, 2015
- Correction of Brain Oligodendrocytes by AAVrh.10 Intracerebral Gene Therapy in Metachromatic Leukodystrophy MiceHuman Gene Therapy, 2012
- Glycosaminoglycan Storage Disorders: A ReviewBiochemistry Research International, 2011
- Metachromatic Leukodystrophy – An UpdateNeuropediatrics, 2010
- Efficient intracerebral delivery of AAV5 vector encoding human ARSA in non-human primateHuman Molecular Genetics, 2009
- Development of Sensory, Motor and Behavioral Deficits in the Murine Model of Sanfilippo Syndrome Type BPLOS ONE, 2007
- Gene therapy for lysosomal storage diseasesMolecular Therapy, 2006